.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Prof. Dr. Klaus Überla

Erlangen / DE

University Erlangen-Nuernberg

Speaker

04/03/2025
16:15 – 16:30 12 Min. 3 Min.
Abstract talk
O 012
Elucidating Sterilizing Immunity Mechanisms Provided by an HIV-1 Neutralizing Antibody Against Mucosal Infection in a Non-Human Primate Model
Adaptive immunity

Further involvements

04/03/2025
Poster
P 295
Development and Characterization of a Human Papillomavirus-Based Nanoparticle Carrier for Heterologous Vaccine Antigens
Viral vectors and vaccines
04/03/2025
Poster
P 306
Influence of the number of T helper cell epitopes of a VLP-vaccine on the magnitude of Intrastructural help
Viral vectors and vaccines
04/03/2025
16:15 – 16:30 12 Min. 3 Min.
Abstract talk
O 012
Elucidating Sterilizing Immunity Mechanisms Provided by an HIV-1 Neutralizing Antibody Against Mucosal Infection in a Non-Human Primate Model
Adaptive immunity
04/03/2025
18:45 – 19:00 12 Min. 3 Min.
Abstract talk
O 021
Inducing mucosal antibody responses against HIV-1 by intrastructural help (ISH) using virus-like particle (VLP) vaccine
Viral vectors and vaccines
05/03/2025
Poster
P 168
Trained immunity within the mononuclear phagocyte precursor pool and its role for anti-viral immune responses
Innate immunity
05/03/2025
11:15 – 11:30 12 Min. 3 Min.
Abstract talk
O 051
Determination of Human Cytomegalovirus (HCMV)-specific antibody signatures in blood donor and patient sera using a FACS-based multiplex assay
Diagnostics and clinical virology
05/03/2025
14:15 – 14:30 12 Min. 3 Min.
Abstract talk
O 069
Utilizing machine learning to study longitudinal immune imprinting effects of SARS-CoV-2 breakthrough infection
Epidemiology and public health
07/03/2025
11:45 – 12:00 12 Min. 3 Min.
Abstract talk
O 115
Optimisation of mRNA encapsulated Lipid nanoparticles (LNPs) for in vivo administration of monoclonal antibodies
Antiviral therapy and resistance